Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.26 USD | +1.26% | -1.83% | -11.65% |
14/05 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
10/05 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
- Stock Market
- Equities
- EXEL Stock
- Charts Exelixis, Inc.
- Static Chart